Pulmatrix Shares Outstanding 2014-2021 | PULM

Pulmatrix shares outstanding from 2014 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pulmatrix Annual Shares Outstanding
(Millions of Shares)
2020 29
2019 17
2018 4
2017 2
2016 1
2015 1
2014 0
2014 0
2013
2013 0
2012 0
Pulmatrix Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 56
2021-03-31 46
2020-12-31 29
2020-09-30 34
2020-06-30 24
2020-03-31 20
2019-12-31 17
2019-09-30 20
2019-06-30 19
2019-03-31 7
2018-12-31 4
2018-09-30 5
2018-06-30 5
2018-03-31 2
2017-12-31 2
2017-09-30 2
2017-06-30 2
2017-03-31 2
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 1
2015-09-30 1
2015-06-30 0
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31 0
2013-09-30 0
2013-06-30 0
2013-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.044B $0.013B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29